Allergy and Immunology, Allergy · Glendale, AZ
NPI
1801821152
Since 2006
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5750 W. Thunderbird Rd #g780
Glendale, AZ, 85306
Phone (602) 314-4220
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
15,203 services
Medicare patients, 2024
304
Average age 75
Drug cost, 2024
$2.4M
1,531 prescriptions
Company payments, 2025
$179K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd M Hrabak was code 95004 (test - miscellaneous), 6,500 times for 80 patients. In total Todd M Hrabak billed 15,203 services in 29 codes, and Medicare paid $205K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 6,500 | 80 | $2.82 | $18K |
| 95165 Treatment - Miscellaneous | Office | 3,692 | 99 | $11.10 | $41K |
| 95117 Treatment - Miscellaneous | Office | 1,144 | 98 | $9.35 | $11K |
| 95024 Test - Miscellaneous | Office | 1,133 | 71 | $6.27 | $7,103 |
| 99214 Office E&M - Established | Office | 538 | 237 | $93.18 | $50K |
| 94010 Pulmonary Function Testing | Office | 415 | 144 | $19.35 | $8,032 |
| 94375 Pulmonary Function Testing | Office | 389 | 194 | $30.81 | $12K |
| 95180 Treatment - Miscellaneous | Office | 202 | 25 | $111.36 | $22K |
| 99497 Care Management/Coordination | Office | 151 | 148 | $65.98 | $9,963 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 129 | 25 | $0.70 | $90 |
| 96372 Injection Administration | Office | 118 | 33 | $10.53 | $1,242 |
| 94060 Pulmonary Function Testing | Office | 79 | 62 | $29.23 | $2,309 |
| 99204 Office E&M - New | Office | 73 | 73 | $116.94 | $8,536 |
| 94729 Pulmonary Function Testing | Office | 29 | 29 | $44.80 | $1,299 |
| 94726 Pulmonary Function Testing | Office | 29 | 29 | $43.34 | $1,257 |
By year: 2022 $229K for 17,242 services; 2023 $211K for 15,305 services; 2024 $205K for 15,203 services.
Medicare prescription drug claims, 2024
In 2024, the drug Todd M Hrabak prescribed most often to Medicare patients was Azithromycin, with 140 prescriptions and refills. In total Todd M Hrabak wrote 1,531 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 140 | 323 | 63 | $1,336 |
| Epinephrine Generic | 130 | 133 | 119 | $24K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 126 | 244 | 36 | $153K |
| Montelukast Sodium Generic | 120 | 264 | 62 | $1,587 |
| Prednisone Generic | 106 | 119 | 79 | $345 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 105 | 105 | Under 11 | $664K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 75 | 94 | 45 | $2,218 |
| Fluticasone Propionate Generic | 71 | 141 | 26 | $1,639 |
| Famotidine Generic | 55 | 77 | 45 | $311 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 55 | 55 | Under 11 | $315K |
| Cuvitru Immun Glob G(Igg)/Gly/Iga Ov50 | 49 | 49 | Under 11 | $333K |
| Azelastine Hcl Generic | 41 | 66 | 21 | $1,330 |
| Breo Ellipta Fluticasone/Vilanterol | 41 | 75 | 11 | $28K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 39 | 75 | 15 | $8,819 |
| Xolair Omalizumab | 32 | 35 | Under 11 | $96K |
Brand drugs: 786 claims; generic drugs: 745 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd M Hrabak $179K ($179K in general payments such as food, travel and fees) from 19 companies. The largest payer was CSL Behring with $66K.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 163 | $66K |
| ARS Pharmaceuticals Operations, Inc. SPRY | 71 | $63K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 86 | $45K |
| GC Biopharma USA, Inc. 006280.KS | 17 | $2,851 |
| GlaxoSmithKline, LLC. GSK | 22 | $335 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $292 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $231 |
| Genzyme Corporation SNY | 16 | $223 |
| Grifols USA, LLC | 7 | $219 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.